Trial Details
COMPLETEDBasic Information
| Clinical ID | c4117 |
|---|---|
| Identifier | NCT01027260 |
| Trial Title | Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: Itopride HCI 50 mg|DRUG: Itopride HCI 100 mg|DRUG: Placebo |
Participant Information
| Sponsor | Abbott |
|---|---|
| City | Karachi |
| Country/Region | Pakistan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2008-06 |
|---|---|
| Primary Completion Date | 2010-08 |
| Completion Date | 2010-09 |